Latest News about BGNE
Recent news which mentions BGNE
As China's Population Declines In 2023, Will Aging Demographics Boost Healthcare Stocks?
January 10, 2024
From Benzinga
HBM Gets Health Boost From Drug Licensing Deals
December 22, 2023
From Benzinga
7 Biotech Stocks to Buy for Big-Time Gains
November 10, 2023
From InvestorPlace
Why Bluegreen Vacations Shares Are Trading Higher By Around 105%? Here Are Other Stocks Moving In Monday's Mid-Day Session
November 06, 2023
From Benzinga
Ryanair Holdings, Prime Medicine And Other Big Stocks Moving Higher In Monday's Pre-Market Session
November 06, 2023
From Benzinga
Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 30, 2023
From Benzinga
Western Digital, JinkoSolar, Lumentum Holdings And Other Big Stocks Moving Higher On Monday
October 30, 2023
From Benzinga
Why Biophytis Shares Are Trading Higher By Over 12%: Here Are 20 Stocks Moving Premarket
October 30, 2023
From Benzinga
Quant Ratings Updated on 62 Stocks
October 24, 2023
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
October 02, 2023
From Benzinga
Citigroup Maintains Buy Rating for BeiGene: Here's What You Need To Know
September 21, 2023
Tickers
BGNE
From Benzinga
Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
September 20, 2023
From Benzinga
From Benzinga
Chinese Drugmaker BeiGene And Novartis Move Out From Second Cancer Drug Pact
September 19, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023
September 12, 2023
From Benzinga
Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
September 11, 2023
From Benzinga
Tesla, Crinetics Pharmaceuticals And Other Big Stocks Moving Higher In Monday's Pre-Market Session
September 11, 2023
From Benzinga
PDD Holdings, UP Fintech Holding, Big Lots And Other Big Stocks Moving Higher On Tuesday
August 29, 2023
From Benzinga
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 17, 2023
August 17, 2023
From Benzinga
Growing Competition in Hematology, Aesthetics Complicates AbbVie's Post-Humira Landscape, Analyst Says
July 25, 2023
From Benzinga
BeiGene's Brukinsa Positioned as Preferred BTK Inhibitor: Analyst Says Survey Supports Bullish View
July 17, 2023
From Benzinga
From Benzinga
Why Are BeiGene Shares Trading Lower Today
July 11, 2023
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.